Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
OPL-015 by Overseas Pharmaceuticals for Pain: Likelihood of Approval
OPL-015 is under clinical development by Overseas Pharmaceuticals and currently in Phase III for Pain. According to GlobalData, Phase III...